Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study.

Journal of Feline Medicine and Surgery
Vicky A IronsideA Boswood

Abstract

This study aimed to identify indicators of the risk of progression of preclinical hypertrophic cardiomyopathy (HCM). This was a prospective cohort study following a population of cats with preclinical HCM. Cats serially underwent physical examination, blood pressure measurement, blood sampling and echocardiography. Development of congestive heart failure (CHF), arterial thromboembolism (ATE) or sudden death (SD) were considered cardiac-related events. Associations between factors recorded at baseline, and on revisit examinations, and the development of a cardiac-related event were explored using receiver operator characteristic (ROC) analysis. Forty-seven cats were recruited to the study and were followed for a median period of 1135 days. Fifteen cats (31.9%) experienced at least one cardiac-related event; six CHF, five ATE and five SD. One cat experienced a cardiac-related event per 10.3 years of patient follow-up. Cats with increased left atrial (LA) size and higher concentrations of N-terminal pro B-type natriuretic peptide (NTproBNP) at baseline were more likely to experience an event. Cats with a greater rate of enlargement of LA size between examinations were also more likely to experience an event. Factors easily measure...Continue Reading

References

May 1, 1993·Journal of Veterinary Internal Medicine·E N PetersonM R Slater
Aug 10, 2000·Journal of Veterinary Internal Medicine·M Rishniw, H N Erb
Jul 20, 2002·Journal of the American Veterinary Medical Association·John E RushDonald J Brown
Jun 2, 2009·Journal of the American Veterinary Medical Association·Christopher F PaigeR Lee Pyle
Feb 27, 2010·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Karsten Schober, Amanda Todd
Nov 16, 2010·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Tobias WagnerDavid Brodbelt
May 21, 2013·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Karsten E SchoberJohn D Bonagura
Oct 19, 2013·Journal of Veterinary Internal Medicine·J R PayneV Luis Fuentes
Jul 25, 2014·Journal of Veterinary Internal Medicine·R LanghornJ Koch
Oct 17, 2014·Journal of Veterinary Internal Medicine·K BorgeatD J Connolly
Jan 19, 2016·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·J R PayneV Luis Fuentes

❮ Previous
Next ❯

Citations

Jan 8, 2021·Frontiers in Veterinary Science·Marie-Pierre Ryser-DegiorgisFrancesco C Origgi
Oct 26, 2021·Journal of Feline Medicine and Surgery·Mark D Kittleson, Etienne Côté

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

The Veterinary Clinics of North America. Small Animal Practice
V Luis Fuentes, L Wilkie
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology
Karsten SchoberJohn D Bonagura
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology
G StanzaniD J Connolly
© 2021 Meta ULC. All rights reserved